Refractory epilepsy associated with anti-ribosomal P antibodies successfully treated with topiramate
Artículo
Open/ Download
Access note
Acceso Abierto
Publication date
2020Metadata
Show full item record
Cómo citar
Uribe San Martín, R.
Cómo citar
Refractory epilepsy associated with anti-ribosomal P antibodies successfully treated with topiramate
Author
Abstract
We report the case of a 25-year-old woman who developed temporal lobe epilepsy associated with systemic lupus erythematosus (SLE). Serum and cerebrospinal fluid samples showed high titers of anti-ribosomal P (anti-P) antibodies with negative anti-NMDAR antibodies. She was receiving prednisone and azathioprine, with normalization of SLE serum markers, but without changes in titers of anti-P antibodies. No seizure control was achieved using valproic acid, levetiracetam and lamotrigine. However, she had a selective response to topiramate, an AMPAR blocker, maintained during 6 years of follow-up. We discuss the pathophysiology of this autoimmune epilepsy associated with high titer anti-P antibodies
Indexation
Artículo de publicación ISI
Identifier
URI: https://repositorio.uchile.cl/handle/2250/174599
DOI: 10.1016/j.jneuroim.2020.577144
Quote Item
Journal of Neuroimmunology 340 (2020) 577144
Collections
The following license files are associated with this item: